VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update

$VNRXPress releaseAug 13, 2026, 4:10 PM ETRead the release

VolitionRx reported second quarter revenue of approximately $0.4 million, flat year-over-year, while first-half revenue grew 112% to $1.4 million. Operating expenses fell 32% in the quarter, driving a 34% reduction in operating loss to $4.2 million, as the company focuses on cost discipline.

Key figures

Revenue: $0.4 million
Revenue Yoy: in line
Atm proceeds: $1.2 million
Operating loss: $4.2 million
H1 2026 revenue: $1.4 million
Net cash used ops: $5.2 million
Offering proceeds: $4.1 million
Expected milestone: $5 million
H1 2026 revenue growth: 112%
Operating expenses reduction: 32%

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.